Lipid Nanoparticles: A New Frontier in Diabetes Treatment.

Sharma B, Ahuja A, Singh AP, Sharma AK.

Open source

DOI
10.2174/0118723128404825250930064303
Published
2026-01-01
Container
Drug Metab Bioanal
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0118723128404825250930064303,
  title = {Lipid Nanoparticles: A New Frontier in Diabetes Treatment.},
  author = {Sharma B and  Ahuja A and  Singh AP and  Sharma AK.},
  year = {2026},
  journal = {Drug Metab Bioanal},
  doi = {10.2174/0118723128404825250930064303},
  url = {https://doi.org/10.2174/0118723128404825250930064303}
}

RIS

TY  - JOUR
TI  - Lipid Nanoparticles: A New Frontier in Diabetes Treatment.
AU  - Sharma B
AU  -  Ahuja A
AU  -  Singh AP
AU  -  Sharma AK.
PY  - 2026
JO  - Drug Metab Bioanal
DO  - 10.2174/0118723128404825250930064303
UR  - https://doi.org/10.2174/0118723128404825250930064303
ER  - 

APA

B, S., A, A., AP, S., & AK., S. (2026). Lipid Nanoparticles: A New Frontier in Diabetes Treatment.. Drug Metab Bioanal. https://doi.org/10.2174/0118723128404825250930064303

Source records